Pricing Log in Create free account

Equillium, Inc. (EQ) vs Genelux Corporation (GNLX)

Equillium, Inc. and Genelux Corporation are both Biotechnology companies. Equillium, Inc. and Genelux Corporation are of similar size ($88.8M and $88.7M). Across the 11 metrics below, Equillium, Inc. leads on 9 and Genelux Corporation on 2.

Valuation

Metric EQ GNLX Biotechnology median
P/E n/m n/m 10.26
P/S 3.65 7.24 9.18
P/B 2.67 5.05 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 2.44 6.33 8.98
Earnings yield (14.93%) (47.51%) (34.89%)
Free cash flow yield (13.40%) (35.25%) (24.52%)

Profitability

Metric EQ GNLX Biotechnology median
Gross margin 100.00% (3.42%) 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.98%) (177.93%) (50.12%)
Return on assets (50.68%) (121.80%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EQ GNLX Biotechnology median
Revenue growth (TTM) 13.89% — 6.26%
EPS growth (last fiscal year) (69.57%) 9.47% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ GNLX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 23.40 2.39 4.89
Net debt to EBITDA 1.29 0.44 1.01

Dividend

Metric EQ GNLX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EQ GNLX Biotechnology median
Market cap 88.78m 88.68m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack